Dermatology Times, November 2022 (Vol. 43. No. 11)

Exploring What’s Possible for HS Treatment

October 22, 2022

At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.

A Study of Immune Checkpoint Inhibitors & Complication Rates

October 10, 2022

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.